Register Online At

Total Page:16

File Type:pdf, Size:1020Kb

Register Online At The IM Network Forum, 2016, will Who should attend: build on the success of the inaugural Integrative Medicine Research Integrative and conventional medicine clinicians, researchers and educators Forum of 2014. We invite you to join interested in learning more about how us for this free half-day conference to integrative medicine research can translate help shape and strengthen the into clinical care and practice. integrative medicine community across Boston. Boston-wide practitioners wishing to connect with others in the integrative This year, the focus will not only be to medicine community. convene the Boston-wide Integrative Medical students seeking to learn more Medicine community as a whole, and about the integrative medicine network in to facilitate connection, cooperation Boston. and collaboration, but to also highlight the contours of the local clinical integrative medicine network. Event Details: Preliminary Format: Date: Friday, November, 18, 2016 Program: 8:00am - 2:00pm 8:00am: Breakfast and Registration Cost: Free Welcome and Introduction: Breaking down silos Venue: Joseph B. Martin Conference Center, Keynote: Dr. Alessio Fasano Harvard Medical School, Boston, MA Clinical Panel Discussion and Q&A: (exploring the clinical translation of Organizers: the Osher Center for Integrative integrative medicine research) Medicine at Harvard Medical School and Networking Break Brigham and Women’s Hospital Integrative Medicine Research Presentations Contact: Aterah Nusrat at p: 617.525.8737; Clinical Medley Presentations e: [email protected] (key integrative medicine institutions from across Boston) Register online at *Launch Event* : Clinical Integrative Medicine Interactive Online map (for www.oshercenter.org practitioners and the public) Networking lunch with research poster viewing Close: 2:00pm KEYNOTE PRESENTATION ALESSIO FASANO, MD W. Allan Walker Professor of Pediatric Gastroenterology at Harvard Medical School Chief of Division of Pediatric Gastroenterology and Nutrition Director of Center for Celiac Research and Treatment Director of Mucosal Immunology and Biology Research Center Associate Chief, Department of Pediatrics, Basic, Clinical and Translational Research MassGeneral Hospital for Children Visiting Professor of Pediatrics, Harvard Medical School World-renowned pediatric gastroenterologist, research scientist and entreprenuer Alessio Fasano, M.D., is the W. Allan Walker Professor of Pediatric Gastroenterology at Harvard Medical School and Chief of the Division of Pediatric Gastroenterology and Nutrition at MassGeneral Hospital for Children. His visionary research has advanced international understanding and awareness of celiac disease and gluten-related disorders. In 2000, he and his team discovered zonulin, which regulates intestinal permeability and can play a role in inflammation and autoimmunity throughout the systems of the body. Dr. Fasano recently authored Gluten Freedom to dispel confusion about gluten and how it can affect your health. PANELISTS ATHER ALI, ND, MPH, MHS Assistant Professor of Pediatrics and Medicine Director, Yale Adult and Pediatric Integrative Medicine Clinic Medical Director, Integrative Medicine Smilow Cancer Hospital at Yale-New Haven Yale School of Medicine Ather Ali, ND, MPH, MHS is Assistant Professor of Pediatrics (General Pediatrics) and of Medicine (General Medicine) at the Yale School of Medicine. He is Director of the Yale Adult and Pediatric Integrative Medicine Clinic and Medical Director or Integrative Medicine at Smilow Cancer Hospital at Yale-New Haven. Dr. Ali is principal investigator of clinical and translational studies in fibromyalgia, irritable bowel syndrome, food sensitivity, nutritional interventions, diagnostic tests, the human microbiome, and integrative medicine outcomes, supported by federal, foundation, and industry sources. ANTHONY J. LEMBO, MD Director, GI Motility Laboratory Beth Israel Deaconess Medical Center Associate Professor, Harvard Medical School Dr. Anthony Lembo has served as Director of the GI Motility Laboratory at the Beth Israel Deaconess Medical Center's (BIDMC) Division of Gastroenterology in Boston, MA and as an Associate Professor of Medicine at Harvard Medical School. He is an accomplished expert in GI Motility Disorders and Irritable Bowel Syndrome. His research interest includes the study of placebo in the treatment of IBS. He divides his time between clinical medicine and research at Beth Israel Deaconess Medical Center in Boston. He has authored numerous original clinical studies and other research articles related to IBS. DONALD B. LEVY, MD Medical Director, Osher Clinical Center for Integrative Medicine Brigham and Women’s Hospital Assistant Professor, Harvard Medical School Dr. Levy is the Medical Director of the Osher Clinical Center. He is a board certified internist and an Assistant Clinical Professor of Medicine at Harvard Medical School. He graduated New York Medical College in 1981 and completed his residency at Mt. Auburn Hospital in Cambridge, MA. Dr. Levy taught Harvard medical students, interns, residents and fellows in a variety of roles for over 25 years and maintained a practice in primary care internal medicine until 2007. He worked at the Marino Center for Progressive Health in Cambridge, MA for over 10 years, where he served as Medical Director for one year, and then staff physician and Director of Integrative Medical Education. He helped the center to expand its multidisciplinary team of practitioners and to ally itself with local academic medical centers, hospitals and research organizations. His professional interests include the use of nutrition and dietary herbs and supplements in medicine, the management of cardiac risks to prevent heart disease, and the integration of scientific advances in modern medicine with the rediscovery and implementation of age-old principles and therapies that enhance the ability to heal and maintain good health. .
Recommended publications
  • Celiac Disease and Nonceliac Gluten Sensitivitya Review
    Clinical Review & Education JAMA | Review Celiac Disease and Nonceliac Gluten Sensitivity A Review Maureen M. Leonard, MD, MMSc; Anna Sapone, MD, PhD; Carlo Catassi, MD, MPH; Alessio Fasano, MD CME Quiz at IMPORTANCE The prevalence of gluten-related disorders is rising, and increasing numbers of jamanetwork.com/learning individuals are empirically trying a gluten-free diet for a variety of signs and symptoms. This review aims to present current evidence regarding screening, diagnosis, and treatment for celiac disease and nonceliac gluten sensitivity. OBSERVATIONS Celiac disease is a gluten-induced immune-mediated enteropathy characterized by a specific genetic genotype (HLA-DQ2 and HLA-DQ8 genes) and autoantibodies (antitissue transglutaminase and antiendomysial). Although the inflammatory process specifically targets the intestinal mucosa, patients may present with gastrointestinal signs or symptoms, extraintestinal signs or symptoms, or both, Author Affiliations: Center for Celiac suggesting that celiac disease is a systemic disease. Nonceliac gluten sensitivity Research and Treatment, Division of is diagnosed in individuals who do not have celiac disease or wheat allergy but who Pediatric Gastroenterology and Nutrition, MassGeneral Hospital for have intestinal symptoms, extraintestinal symptoms, or both, related to ingestion Children, Boston, Massachusetts of gluten-containing grains, with symptomatic improvement on their withdrawal. The (Leonard, Sapone, Catassi, Fasano); clinical variability and the lack of validated biomarkers for nonceliac gluten sensitivity make Celiac Research Program, Harvard establishing the prevalence, reaching a diagnosis, and further study of this condition Medical School, Boston, Massachusetts (Leonard, Sapone, difficult. Nevertheless, it is possible to differentiate specific gluten-related disorders from Catassi, Fasano); Shire, Lexington, other conditions, based on currently available investigations and algorithms.
    [Show full text]
  • NIH Public Access Author Manuscript Psychiatr Q
    NIH Public Access Author Manuscript Psychiatr Q. Author manuscript; available in PMC 2013 May 02. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Psychiatr Q. 2012 March ; 83(1): 91–102. doi:10.1007/s11126-011-9186-y. Neurologic and Psychiatric Manifestations of Celiac Disease and Gluten Sensitivity Jessica R. Jackson, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Box 21247, Baltimore, MD 21228, USA William W. Eaton, Johns Hopkins School of Public Health, Johns Hopkins University School of Medicine, Baltimore, MD, USA Nicola G. Cascella, Johns Hopkins School of Public Health, Johns Hopkins University School of Medicine, Baltimore, MD, USA Alessio Fasano, and Center for Celiac Research, University of Maryland School of Medicine, Baltimore, MD, USA Deanna L. Kelly Maryland Psychiatric Research Center, University of Maryland School of Medicine, Box 21247, Baltimore, MD 21228, USA Deanna L. Kelly: [email protected] Abstract Celiac Disease (CD) is an immune-mediated disease dependent on gluten (a protein present in wheat, rye or barley) that occurs in about 1% of the population and is generally characterized by gastrointestinal complaints. More recently the understanding and knowledge of gluten sensitivity (GS), has emerged as an illness distinct from celiac disease with an estimated prevalence 6 times that of CD. Gluten sensitive people do not have villous atrophy or antibodies that are present in celiac disease, but rather they can test positive for antibodies to gliadin. Both CD and GS may present with a variety of neurologic and psychiatric co-morbidities, however, extraintestinal symptoms may be the prime presentation in those with GS.
    [Show full text]
  • Tempters and Gluten-Free Diet
    nutrients Editorial Tempters and Gluten-Free Diet Carlo Catassi 1,* and Alessio Fasano 2,* 1 Department of Pediatrics, Università Politecnica delle Marche, Ancona 60121, Italy 2 Pediatric Gastroenterology and Nutrition, MassGeneral Hospital for Children, Boston, MA 02129, USA * Correspondence: [email protected] (C.C.); [email protected] (A.F.); Tel.: +39-071-596-2364 (C.C.); +1-617-726-1450 (A.F.) Received: 16 November 2016; Accepted: 25 November 2016; Published: 3 December 2016 To the tempter that came to Him and said, “If You are the Son of God, tell these stones to become bread”. Jesus replied “It is written: man shall not live on bread alone ... ” (Matthew 4:4). Nowadays, many people, particularly in the Western world, have gone well beyond that holy recommendation. In a 2014 US Consumer Reports survey, 63% of participants said they felt that avoiding bread and other gluten-containing food would improve their physical or mental health. Moreover, in a 2015 Gallup Poll, 21% of Americans reported they tried to include gluten-free foods in their diet. The “fall” of gluten might be related to the increased awareness of gluten-related disorders and the recent surge of prevalence of celiac disease (CD) and non-celiac gluten sensitivity (NCGS). This trend could still be on the rise, particularly in areas of the world undergoing a progressive “Westernization” of the diet, as suggested here by Peña and coworkers who note that the diet of people living in Central America is shifting from a maize- to a wheat-based diet [1]. Not surprisingly in Mexico Ontiveros et al.
    [Show full text]
  • Gluten Sensitivity: Real Or Not (People Shall Not Live by Bread Alone..)
    9/17/2013 Gluten Sensitivity: Real or Not (People Shall Not Live by Bread Alone..) Alessio Fasano, M.D. Mucosal Immunology and Biology Research Center And Center for Celiac Research Massachusetts General Hospital, Boston MA – U.S.A. Conflict of Interest In the past 12 months, I have had the following relevant financial relationships with the following manufacturer of any commercial product(s) and/or provider(s) of commercial services discussed in this CME activity: ALBA THERAPEUTICS, CO-FOUNDER AND STOCK HOLDER I will not discuss any product from Alba Therapeutics in my presentation. I do not intend to discuss an unapproved or investigative use of a commercial product or device in my presentation. NEWS #1: Why Gluten is Toxic 1 9/17/2013 Dietary Factors The Grass Family - (GRAMINEAE) Subfamily Festucoideae Tribe Hordeae Oryzeae Zizaneae Aveneae Festuceaea Chlorideae Wheat rice wild rice oat finger millet teff Years rye 2.5 M 2009 The Human race appears on the face of hearth barley 10,000 Change from nomadic to settled life style Diet Fruits, nuts, tubers Occasional meat Advent of agriculture Development of gluten containing grains Grain Evolution + T. turgidum AABB Aegilops tauschii DD T. aestivum AABBDD 28 chromosomes 14 chromosomes 42 chromosomes 100,000 genes 50,000 genes 150,000 genes THE GRAINS IN THE PAST WERE DIFFERENT FROM THE CURRENT GRAINS Pieter Bruegel, 1565 2 9/17/2013 What is so Special About Gluten? Gliadin Glutenin Gluten (gliadin+glutenin) Mapping of -gliadin motifs exerting cytotoxic activity (red), immunomodulatory activity (light green), zonulin release and gut permeating activity (blue) and CXCR3- dependent IL8 release in CD patients (dark green).
    [Show full text]
  • Microbiota and Metabolomic Patterns in the Breast Milk of Subjects with Celiac Disease on a Gluten-Free Diet
    nutrients Article Microbiota and Metabolomic Patterns in the Breast Milk of Subjects with Celiac Disease on a Gluten-Free Diet Katherine L. Olshan 1,2,3,4, Ali R. Zomorrodi 1,2,3,4, Meritxell Pujolassos 5 , Jacopo Troisi 5,6,7 , Nayeim Khan 8, Brian Fanelli 8, Victoria Kenyon 2,4, Alessio Fasano 1,2,3,4,6 and Maureen M. Leonard 1,2,3,4,* 1 Division of Pediatric Gastroenterology and Nutrition, MassGeneral Hospital for Children, Harvard Medical School, Boston, MA 02114, USA; [email protected] (K.L.O.); [email protected] (A.R.Z.); [email protected] (A.F.) 2 Mucosal Immunology and Biology Research Center, MassGeneral Hospital for Children, Boston, MA 02129, USA; [email protected] 3 Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA 02115, USA 4 Celiac Research Program, Harvard Medical School, Boston, MA 02115, USA 5 Theoreo srl, University of Salerno, 84084 Salerno, Italy; [email protected] (M.P.); [email protected] (J.T.) 6 Department of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, 84084 Salerno, Italy 7 European Biomedical Research Institute of Salerno (EBRIS), Via S. De Renzi, 50, 84125 Salerno, Italy 8 CosmosID Inc., Rockville, MD 20850, USA; [email protected] (N.K.); [email protected] (B.F.) * Correspondence: [email protected] Abstract: The intestinal microbiome may trigger celiac disease (CD) in individuals with a genetic disposition when exposed to dietary gluten. Research demonstrates that nutrition during infancy Citation: Olshan, K.L.; Zomorrodi, is crucial to the intestinal microbiome engraftment.
    [Show full text]
  • Non-Celiac Gluten Sensitivity: the New Frontier of Gluten Related Disorders
    Non-Celiac Gluten Sensitivity: The New Frontier of Gluten Related Disorders The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Catassi, C., J. C. Bai, B. Bonaz, G. Bouma, A. Calabrò, A. Carroccio, G. Castillejo, et al. 2013. “Non-Celiac Gluten Sensitivity: The New Frontier of Gluten Related Disorders.” Nutrients 5 (10): 3839-3853. doi:10.3390/nu5103839. http://dx.doi.org/10.3390/nu5103839. Published Version doi:10.3390/nu5103839 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879062 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Nutrients 2013, 5, 3839-3853; doi:10.3390/nu5103839 OPEN ACCESS nutrients ISSN 2072-6643 www.mdpi.com/journal/nutrients Review Non-Celiac Gluten Sensitivity: The New Frontier of Gluten Related Disorders Carlo Catassi 1, Julio C. Bai 2, Bruno Bonaz 3, Gerd Bouma 4, Antonio Calabrò 5, Antonio Carroccio 6, Gemma Castillejo 7, Carolina Ciacci 8, Fernanda Cristofori 9, Jernej Dolinsek 10, Ruggiero Francavilla 9, Luca Elli 11, Peter Green 12, Wolfgang Holtmeier 13, Peter Koehler 14, Sibylle Koletzko 15, Christof Meinhold 16, David Sanders 17, Michael Schumann 18, Detlef Schuppan 19,20, Reiner Ullrich 18, Andreas Vécsei 21, Umberto Volta 22, Victor Zevallos 19, Anna Sapone 23 and Alessio Fasano 24,* 1 Department of Pediatrics, Università Politecnica delle Marche, Ancona 60121, Italy; E-Mail: [email protected] 2 Departamento de Medicina, Hospital de Gastroenterología “Dr.
    [Show full text]
  • Role of Zonulin-Mediated Gut Permeability in the Pathogenesis of Some Chronic Inflammatory Diseases [Version 1; Peer Review: 3 Approved] Alessio Fasano 1,2
    F1000Research 2020, 9(F1000 Faculty Rev):69 Last updated: 24 FEB 2020 REVIEW All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases [version 1; peer review: 3 approved] Alessio Fasano 1,2 1Mucosal Immunology and Biology Research Center, Center for Celiac Research and Treatment and Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital for Children, Boston, Massachusetts, USA 2European Biomedical Research Institute of Salerno, Salerno, Italy First published: 31 Jan 2020, 9(F1000 Faculty Rev):69 ( Open Peer Review v1 https://doi.org/10.12688/f1000research.20510.1) Latest published: 31 Jan 2020, 9(F1000 Faculty Rev):69 ( https://doi.org/10.12688/f1000research.20510.1) Reviewer Status Abstract Invited Reviewers Improved hygiene leading to reduced exposure to microorganisms has 1 2 3 been implicated as one possible cause for the recent “epidemic” of chronic inflammatory diseases (CIDs) in industrialized countries. That is the version 1 essence of the hygiene hypothesis that argues that rising incidence of CIDs 31 Jan 2020 may be, at least in part, the result of lifestyle and environmental changes that have made us too “clean” for our own good, so causing changes in our microbiota. Apart from genetic makeup and exposure to environmental triggers, inappropriate increase in intestinal permeability (which may be F1000 Faculty Reviews are written by members of influenced by the composition of the gut microbiota), a “hyper-belligerent” the prestigious F1000 Faculty. They are immune system responsible for the tolerance–immune response balance, commissioned and are peer reviewed before and the composition of gut microbiome and its epigenetic influence on the publication to ensure that the final, published version host genomic expression have been identified as three additional elements in causing CIDs.
    [Show full text]
  • Click on Alessio Fasano MD Webinar Description Page
    11/5/2018 COPE WEBINAR SERIES FOR HEALTH PROFESSIONALS November 5, 2018 Gluten-Related Disorders: How to Distinguish Facts from Fantasies Moderator: Lisa Diewald MS, RD, LDN Program Manager MacDonald Center for Obesity Prevention and Education Nursing Education Continuing Education Programming Research FINDING SLIDES FOR TODAY’S WEBINAR www.villanova.edu/COPE Click on Alessio Fasano MD webinar description page DID YOU USE YOUR PHONE TO ACCESS THE WEBINAR? If you are calling in today rather than using your computer to log on, and need CE credit, please email [email protected] and provide your name so we can send your certificate. 1 11/5/2018 OBJECTIVES 1.Recognize the differences between celiac disease, non-celiac gluten sensitivity and wheat allergy. 2.Discuss the epidemiology of celiac disease and why prevalence is increasing 3.Identify the role of the gut microbiome and intestinal permeability in autoimmune disease CE DETAILS • Villanova University College of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center Commission on Accreditation • Villanova University College of Nursing Continuing Education/COPE is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration • The American College of Sports Medicine’s Professional Education Committee certifies that Villanova University College of Nursing Continuing Education, Center for Obesity Prevention and Education (COPE) meets the criteria for official ACSM Approved Provider status
    [Show full text]
  • Fall 2014 Gluten Free New England
    FALL 2014 Gluten Free New England IN THIS ISSUE • Upcoming Meetings • Around the Nation • Celiac Brain Fog • A Gluten Free Thanksgiving neco 617-262-5422 or 888-4-CELIAC 1 www.neceliac.org • 1.888.4.CELIAC New England Celiac Organization — formerly The Healthy Villi Gluten Free New England Magazine | Fall 2014 Gluten Free Serving the Celiac Community New England Magazine of New England In this issue Contact Us Autumn Workshop Meeting & Other Upcoming Events .... 3 New England Celiac Organization NECO - State of the Organization .................................... 4 Phone Line Eat More Beans .............................................................. 7 Information and support is just a phone call Twenty Something Celiac: Reality Check ........................ 9 away. Leave a message, and a board member Book Review: The How Can it Be Gluten Free will return your call within 48 hours. Cookbook .................................................................... 11 Boston area: (617) 262-5422 Around the Nation ......................................................... 12 Toll-free: 1-888-4-CELIAC NECO - Membership Forum .......................................... 14 Website: www.neceliac.org Expanding My Horizons ................................................. 15 Updated regularly with local events and GF Fall Cook’s Corner ......................................................... 17 restaurant listings. You can join, renew, donate, Celiac Brain Fog ............................................................ 19 register for meetings,
    [Show full text]
  • Nutrients Special Issue Book
    IMPACT FACTOR 3.759 nutrients Special Issue Book Gluten Related Disorders: People Shall not Live on Bread Alone Edited by Carlo Catassi and Alessio Fasano http://www.mdpi.com/books/pdfview/book/283 ISBN 978-3-03842-356-0 (print) • ISBN 978-3-03842-357-7 (electronic) Once upon a time, gluten was not part of the human diet, and therefore, there were no gluten-related disorders. With the advent of agriculture 10,000 years ago, the introduction of gluten-containing grains in the human diet created conditions for human diseases related to gluten exposure. These diseases, including celiac disease, non-celiac gluten sensitivity, and wheat allergy, have distinct pathophysiological mechanisms, serological markers, and long-term treatments, but similar, often overlapping clinical presentations. Though current research strives to clarify the boundaries between these entities, their differences can be difficult to distinguish. For a very long time, awareness of these disorders has been limited and, therefore, the epidemiology of gluten-related disorders has been a “work in progress”. New epidemiological studies have revealed that gluten-related disorders are not limited to European regions; rather, they are present worldwide. After centuries of neglected attention to celiac disease and other forms of gluten reaction, now we are observing another interesting phenomenon that is generating great confusion among health care professionals. Nearly 25% of Americans (many more than the projected 3 million celiac disease (CD) patients in the U.S.) are reducing or cutting gluten from their diets. This remarkable trend in the general population reflects the misconception that gluten can be harmful for everybody and, therefore, should be avoided to stay healthy, to lose weight, or even to prevent severe diseases.
    [Show full text]
  • From Ptolemaus to Copernicus: the Evolving System of Gluten-Related Disorder
    nutrients From Ptolemaus to Copernicus: The Evolving System of Gluten-Related Disorder Edited by Carlo Catassi and Alessio Fasano Printed Edition of the Special Issue Published in Nutrients www.mdpi.com/journal/nutrients From Ptolemaus to Copernicus: The Evolving System of Gluten-Related Disorder Special Issue Editors Carlo Catassi Alessio Fasano MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editors Carlo Catassi Universita` Politecnica delle Marche Italy Alessio Fasano Massachusetts General Hospital East USA Editorial Office MDPI AG St. Alban-Anlage 66 Basel, Switzerland This edition is a reprint of the Special Issue published online in the open access journal Nutrients (ISSN 2072-6643) from 2016–2017 (available at: http://www.mdpi.com/journal/nutrients/special issues/ evolving system gluten disorders). For citation purposes, cite each article independently as indicated on the article page online and as indicated below: Lastname, F.M.; Lastname, F.M. Article title. Journal Name. Year. Article number, page range. First Edition 2018 ISBN 978-3-03842-731-5 (Pbk) ISBN 978-3-03842-732-2 (PDF) Articles in this volume are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book taken as a whole is c 2018 MDPI, Basel, Switzerland, distributed under the terms and conditions of the Creative Commons license CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
    [Show full text]
  • Non-Celiac Gluten Sensitivity: the New Frontier of Gluten Related Disorders
    Nutrients 2013, 5, 3839-3853; doi:10.3390/nu5103839 OPEN ACCESS nutrients ISSN 2072-6643 www.mdpi.com/journal/nutrients Review Non-Celiac Gluten Sensitivity: The New Frontier of Gluten Related Disorders Carlo Catassi 1, Julio C. Bai 2, Bruno Bonaz 3, Gerd Bouma 4, Antonio Calabrò 5, Antonio Carroccio 6, Gemma Castillejo 7, Carolina Ciacci 8, Fernanda Cristofori 9, Jernej Dolinsek 10, Ruggiero Francavilla 9, Luca Elli 11, Peter Green 12, Wolfgang Holtmeier 13, Peter Koehler 14, Sibylle Koletzko 15, Christof Meinhold 16, David Sanders 17, Michael Schumann 18, Detlef Schuppan 19,20, Reiner Ullrich 18, Andreas Vécsei 21, Umberto Volta 22, Victor Zevallos 19, Anna Sapone 23 and Alessio Fasano 24,* 1 Department of Pediatrics, Università Politecnica delle Marche, Ancona 60121, Italy; E-Mail: [email protected] 2 Departamento de Medicina, Hospital de Gastroenterología “Dr. Carlos Bonorino Udaondo”, Buenos Aires 1264, Argentina; E-Mail: [email protected] 3 Department of Gastroenterology and Liver Diseases, CHU Grenoble 38043, France; E-Mail: [email protected] 4 Department of Gastroenterology and Hepatology, Vrije Universiteit Medical Center, Amsterdam 1081 HV, The Netherlands; E-Mail: [email protected] 5 Gastroenterology Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence 50134, Italy; E-Mail: [email protected] 6 Department of Internal Medicine, “Giovanni Paolo II” Hospital, Sciacca (AG) and University of Palermo, Sciacca 92019, Italy; E-Mail: [email protected] 7 Pediatric Gastroenterology
    [Show full text]